Combined vitamin B6-magnesium treatment in autism spectrum disorder.
Background: The use of mega-vitamin intervention began in the 1950s with the treatment of schizophrenic patients. Pyroxidine (vitamin B6) was first used with children diagnosed with 'autism syndrome' when speech and language improvement was observed in some children as a result of large doses of B6. A number of studies attempted to assess the effects of vitamin B6-Magnesium (Mg) was found to reduce undesirable side effects from B6) on characteristics such as verbal communication, non-verbal communication, interpersonal skills, and physiological function, in individuals with autism.
Nye, C., & Brice, A. (2005). Combined vitamin B6‐magnesium treatment in autism spectrum disorder. Cochrane Database of Systematic Reviews, (4) doi:10.1002/14651858.CD003497.pub2
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-No Derivative Works 4.0 International License.